Drug Shortage Report for LOESTRIN 1.5/30
Report ID | 130389 |
Drug Identification Number | 00297143 |
Brand name | LOESTRIN 1.5/30 |
Common or Proper name | Loestrin |
Company Name | ALLERGAN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NORETHINDRONE ACETATE ETHINYL ESTRADIOL |
Strength(s) | 1.5MG 30MCG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 5x21 |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-10-16 |
Estimated end date | 2021-01-19 |
Actual end date | 2021-01-19 |
Shortage status | Resolved |
Updated date | 2021-01-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-01-20 | English | Compare |
v4 | 2021-01-19 | French | Compare |
v3 | 2021-01-19 | English | Compare |
v2 | 2020-12-18 | French | Compare |
v1 | 2020-12-18 | English | Compare |
Showing 1 to 5 of 5